Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use

• Auteurs principaux: D. V. Kurkin (Auteur), D. A. Bakulin (Auteur), E. I. Morkovin (Auteur), A. V. Strygin (Auteur), Yu. V. Gorbunova (Auteur), E. V. Volotova (Auteur), I. E. Makarenko (Auteur), V. B. Saparova (Auteur), R. V. Drai (Auteur), V. I. Petrov (Auteur)
• Format: Livre
• Publié: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2023-05-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Modern requirements for the treatment of type 2 diabetes mellitus (DM2) include not only achieving a glycemic control, but also reducing the risk of developing cardiovascular complications. Dipeptidyl peptidase 4 (DPP-4) inhibitors are inferior in the effectiveness to some other actively developing...